Lupin, ForDoz Pharma ink distribution pact for 2 complex injectable drugs under development
Advertisement
Mumbai: Pharma major Lupin Limited has announced that its U.S. based wholly-owned subsidiary Lupin Pharmaceuticals Inc. has entered into an agreement with ForDoz Pharma Corp for granting Lupin the exclusive rights to market and distribute 2 complex injectable assets in advanced stages of development in the U.S. and its territories.
The two assets are in the Oncology and Anti-infective therapeutic areas which when approved, will provide affordable alternatives to patients and healthcare professionals.
The assets will be manufactured in ForDoz's U.S. based manufacturing site and ForDoz will be responsible for the development and obtaining the necessary regulatory approvals. Lupin shall leverage its existing commercial infrastructure for the marketing and distribution of the two assets.
Commenting on the development Alok Sonig, CEO, US Generics and Global Head, Generics R&D and Biosimilars for Lupin said, "The partnered assets are a key, strategic addition to our complex injectables pipeline and will bolster our Institutional business offering. These assets will complement Lupin's ongoing organic R&D efforts in complex assets including inhalation and long-acting injectables as well as Biosimilars."
According to James He, Founder, and CEO of ForDoz Pharma Corp, "ForDoz Pharma is excited to partner our complex injectable flagship products with Lupin. Lupin's leadership presence in the U.S. will complement ForDoz's scientific and complex injectable manufacturing capability to bring affordable medicines to patients in an efficient manner".
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.